LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

Search

Phibro Animal Health Corp

Fermé

SecteurSoins de santé

40.45 2.04

Résumé

Variation du prix de l'action

24h

Actuel

Min

39.1

Max

41.4

Chiffres clés

By Trading Economics

Revenu

9.3M

27M

Ventes

-15M

364M

P/E

Moyenne du Secteur

24

77.671

BPA

0.73

Rendement du dividende

1.23

Marge bénéficiaire

7.29

Employés

2,475

EBITDA

22M

63M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+19.14% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

1.23%

2.35%

Date du Prochain Dividende

17 déc. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-133M

1.6B

Ouverture précédente

38.41

Clôture précédente

40.45

Sentiment de l'Actualité

By Acuity

20%

80%

53 / 374 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Phibro Animal Health Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

10 déc. 2025, 22:02 UTC

Résultats

Synopsys Sees Strong 2026 as Ansys Acquisition Boosts 4Q Revenue

10 déc. 2025, 21:46 UTC

Résultats

Adobe Expects Double-Digit Recurring Revenue Growth Next Year

10 déc. 2025, 23:52 UTC

Acquisitions, Fusions, Rachats

Paramount Sends Letter to Warner Bros. Shareholders Saying Its Offer Is 'Superior' -- Barrons.com

10 déc. 2025, 23:43 UTC

Market Talk

Nikkei May Rise After Fed Rate Cut -- Market Talk

10 déc. 2025, 23:36 UTC

Market Talk

Gold Consolidates as Traders Digest FOMC Decision -- Market Talk

10 déc. 2025, 23:20 UTC

Résultats

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- 2nd Update

10 déc. 2025, 23:15 UTC

Résultats

Synopsys Targets Double-Digit Growth Following Ansys Acquisition -- Interview

10 déc. 2025, 22:59 UTC

Market Talk
Résultats
Acquisitions, Fusions, Rachats

Adobe Expects Semrush Deal to Bring in New Users -- Market Talk

10 déc. 2025, 22:45 UTC

Market Talk

Coca-Cola's New CEO Pick Looks A Lot Like The Last One -- Market Talk

10 déc. 2025, 22:40 UTC

Résultats

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10 déc. 2025, 22:06 UTC

Acquisitions, Fusions, Rachats

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10 déc. 2025, 22:06 UTC

Résultats

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10 déc. 2025, 22:02 UTC

Résultats

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10 déc. 2025, 22:00 UTC

Résultats

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- Update

10 déc. 2025, 21:53 UTC

Résultats

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10 déc. 2025, 21:50 UTC

Acquisitions, Fusions, Rachats

Investors Bet That a Higher Bid for Warner Is Coming -- Update

10 déc. 2025, 21:50 UTC

Market Talk
Résultats
Acquisitions, Fusions, Rachats

Financial Services Roundup: Market Talk

10 déc. 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

10 déc. 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

10 déc. 2025, 21:45 UTC

Acquisitions, Fusions, Rachats

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10 déc. 2025, 21:33 UTC

Résultats

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- WSJ

10 déc. 2025, 21:32 UTC

Résultats

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10 déc. 2025, 21:28 UTC

Acquisitions, Fusions, Rachats

Sverica Capital Management Announces Sale of Coastal Cloud Holdings to Tata Consultancy Services for $700M

10 déc. 2025, 21:25 UTC

Résultats

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10 déc. 2025, 21:18 UTC

Acquisitions, Fusions, Rachats

Paramount Skydance: Company Has Air Tight Financing to Deliver on Warner Bros. Offer >PSKY

10 déc. 2025, 21:16 UTC

Résultats

Oracle Reports Mixed Earnings. The Stock is Falling. -- Barrons.com

10 déc. 2025, 21:15 UTC

Acquisitions, Fusions, Rachats

Paramount Skydance: Public Offer for Warner Bros. Delivers Superior Value, Faster, More Certain Path to Completion

10 déc. 2025, 21:15 UTC

Résultats

Oracle: 'Sold Ampere Because We No Longer Think It Is Strategic for Us to Continue Designing, Manufacturing and Using Our Own Chips in Our Cloud Datacenters' >ORCL

10 déc. 2025, 21:14 UTC

Résultats

Oracle 2Q Non-GAAP Operating Income Was $6.7 B >ORCL

10 déc. 2025, 21:14 UTC

Résultats

Oracle 2Q GAAP Operating Income Was $4.7 B >ORCL

Comparaison

Variation de prix

Phibro Animal Health Corp prévision

Objectif de Prix

By TipRanks

19.14% hausse

Prévisions sur 12 Mois

Moyen 47.5 USD  19.14%

Haut 50 USD

Bas 45 USD

Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

2 ratings

1

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

17 / N/ASupport & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Weak Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

53 / 374Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Phibro Animal Health Corp

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.
help-icon Live chat